Metraipolis › archive › dc_aa3c1db484ed
PSMA-Based Radiopharmaceuticals in Prostate Cancer Theranostics: Imaging, Clinical Advances, and Future Directions — Europe PMC PMID:41595153
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41595153
- DOI
- 10.3390/cancers18020234
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T22:02:35.245Z
- SHA-256 of the archived text
eedc223a229171801c73cf3adaba6d351d5322b0d19ddbe674dec754dd48ac6d- Stable URL of this page
https://metraipolis.com/documento/dc_aa3c1db484ed
How to cite
PSMA-Based Radiopharmaceuticals in Prostate Cancer Theranostics: Imaging, Clinical Advances, and Future Directions — Europe PMC PMID:41595153 — Europe PMC (en), https://europepmc.org/article/MED/41595153 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aa3c1db484ed (Metraipolis archive dc_aa3c1db484ed, sha256 eedc223a229171801c73cf3adaba6d351d5322b0d19ddbe674dec754dd48ac6d)
BibTeX
@misc{dcaa3c1db484ed,
title = {PSMA-Based Radiopharmaceuticals in Prostate Cancer Theranostics: Imaging, Clinical Advances, and Future Directions — Europe PMC PMID:41595153},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41595153},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aa3c1db484ed; sha256 eedc223a229171801c73cf3adaba6d351d5322b0d19ddbe674dec754dd48ac6d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41595153. Agents can read the archived copy with the MCP tool read_document.